Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Platelet-rich plasma shows promise for skin and hair treatments but needs more research and standardization.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Mycophenolic acid may help hair grow by activating pathways important for hair growth.

Choose hair restoration surgery candidates carefully and plan treatments for a natural look and future hair loss.

Inflammation affects hair loss; anti-inflammatory treatments may help.

A female runner's hair loss was caused by stress from surgery and recovery, but her hair returned to normal in 5 months.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Platelet-rich plasma helps hair regrowth and improves quality of life in women with hair loss, but minoxidil may be more effective.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Injectable platelet-rich fibrin improves hair growth and reduces hair loss in women.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.